Literature DB >> 28435994

Thalassemia Minor and Major: Current Management.

Ved Prakash Choudhry1,2.   

Abstract

Thalassemia is a common genetic disorder. It has been estimated that in India nearly 5 crore people are thalassemia carriers. They are asymptomatic and are detected on blood tests. These people are at same risk of developing iron deficiency anemia as general population and need iron therapy in the presence of iron deficiency anemia. Nearly 12,000 children with thalassemia major (Homozygous state) are born every year. These children often present with significant anemia along with hepatosplenomegaly during infancy and require early diagnosis and institution of therapy with repeated blood transfusions and chelation therapy. Adequate dose of chelation therapy is essential to maintain serum ferritin around 1000 ng/ml. With present protocol of management, thalassemic children have near normal life. Bone marrow transplantation offers cure for these children; results of bone marrow transplantation are best when performed below 7 y of age.

Entities:  

Keywords:  Chelation therapy; Long term survivals; Thalassemia major; Thalassemia minor

Mesh:

Year:  2017        PMID: 28435994     DOI: 10.1007/s12098-017-2325-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

1.  The life of patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 2.  Optimal management of β thalassaemia intermedia.

Authors:  Ali T Taher; Khaled M Musallam; Maria Domenica Cappellini; David J Weatherall
Journal:  Br J Haematol       Date:  2011-01-20       Impact factor: 6.998

3.  Deferiprone, efficacy and safety.

Authors:  V P Choudhry; H P Pati; Anita Saxena; A N Malaviya
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 4.  Stem cell transplantation in India.

Authors:  M Chandy
Journal:  Bone Marrow Transplant       Date:  2008-08       Impact factor: 5.483

5.  Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study.

Authors:  D Mohanty; R B Colah; A C Gorakshakar; R Z Patel; D C Master; J Mahanta; S K Sharma; U Chaudhari; M Ghosh; S Das; R P Britt; S Singh; C Ross; L Jagannathan; R Kaul; D K Shukla; V Muthuswamy
Journal:  J Community Genet       Date:  2012-10-21
  5 in total
  8 in total

1.  Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Authors:  Roswitha Lüftinger; Natalia Zubarovskaya; Christina Peters; Arjan Lankester; Selim Corbacioglu; Jacques-Emmanuel Galimard; Annamaria Cseh; Elisabeth Salzer; Franco Locatelli; Mattia Algeri; Akif Yesilipek; Josu de la Fuente; Antonella Isgrò; Amal Alseraihy; Emanuele Angelucci; Frans J Smiers; Giorgia La La Nasa; Marco Zecca; Tunc Fisgin; Emel Unal; Katharina Kleinschmidt
Journal:  Ann Hematol       Date:  2022-01-09       Impact factor: 3.673

2.  Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India.

Authors:  Rakesh Dhanya; Amit Sedai; Kumari Ankita; Lalith Parmar; Rajat Kumar Agarwal; Santhosh Hegde; Gayathri Ramaswami; Ashwini Gowda; S Girija; Pooja Gujjal; H Pushpa; J Dasaratha Ramaiah; Chandrakala Karri; Sujata Jali; Neelavva Rayappa Tallur; U V Shenoy; Diana Pinto; Stalin Ramprakash; C P Raghuram; Deepa Trivedi; Xueyuan Cao; Lawrence Faulkner
Journal:  Blood Adv       Date:  2020-04-14

3.  Coexistence of urticaria pigmentosa and thalassemia minor in a young adult.

Authors:  Funda Tamer; Haldun Umudum
Journal:  Dermatol Pract Concept       Date:  2018-04-30

4.  Who will guard the guardians? Cross-sectional study on prevalence of psychiatric morbidity, quality of life, and coping skills in caregivers of children with thalassemia major.

Authors:  A Y Angane; K S Kadam; G S Ghorpade; V B Unnithan
Journal:  J Postgrad Med       Date:  2022 Apr-Jun       Impact factor: 1.566

5.  The Evaluation of Results of Twenty Common Equations for Differentiation of Beta Thalassemia Trait from Iron Deficiency Anemia: A Cross-Sectional Study.

Authors:  Hassan Ebrahimpour Sadagheyani; Rahim Sharafkhani; Shahriar Sakhaei; Hamid Jafaralilou; Parviz Shahmirzalou
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

6.  Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.

Authors:  Ludovica Aliberti; Irene Gagliardi; Maria Rita Gamberini; Andrea Ziggiotto; Martina Verrienti; Aldo Carnevale; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
Journal:  Br J Haematol       Date:  2022-06-29       Impact factor: 8.615

7.  Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen.

Authors:  Qixin Sun; Bingyi Wu; Hekui Lan; Fanyi Meng; Xiaoxiao Ma; Xinxin Chen; Zhiwei Huang; Qianqian Yao; Jianhui Xu; Yuxian Huang; Shaojie Wu; Zhigang Zhu
Journal:  Br J Haematol       Date:  2018-07-01       Impact factor: 6.998

Review 8.  Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).

Authors:  Fareeha Amjad; Tamseel Fatima; Tuba Fayyaz; Muhammad Aslam Khan; Muhammad Imran Qadeer
Journal:  Biomed Rep       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.